498 related articles for article (PubMed ID: 28553956)
1. Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression.
Kramer N; Schmöllerl J; Unger C; Nivarthi H; Rudisch A; Unterleuthner D; Scherzer M; Riedl A; Artaker M; Crncec I; Lenhardt D; Schwarz T; Prieler B; Han X; Hengstschläger M; Schüler J; Eferl R; Moriggl R; Sommergruber W; Dolznig H
Oncogene; 2017 Sep; 36(39):5460-5472. PubMed ID: 28553956
[TBL] [Abstract][Full Text] [Related]
2. Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms.
Unger C; Kramer N; Unterleuthner D; Scherzer M; Burian A; Rudisch A; Stadler M; Schlederer M; Lenhardt D; Riedl A; Walter S; Wernitznig A; Kenner L; Hengstschläger M; Schüler J; Sommergruber W; Dolznig H
Oncogene; 2017 Sep; 36(38):5341-5355. PubMed ID: 28534511
[TBL] [Abstract][Full Text] [Related]
3. Wnt2 complements Wnt/β-catenin signaling in colorectal cancer.
Jung YS; Jun S; Lee SH; Sharma A; Park JI
Oncotarget; 2015 Nov; 6(35):37257-68. PubMed ID: 26484565
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated fibroblasts secrete Wnt2 to promote cancer progression in colorectal cancer.
Aizawa T; Karasawa H; Funayama R; Shirota M; Suzuki T; Maeda S; Suzuki H; Yamamura A; Naitoh T; Nakayama K; Unno M
Cancer Med; 2019 Oct; 8(14):6370-6382. PubMed ID: 31468733
[TBL] [Abstract][Full Text] [Related]
5. Wnt2 secreted by tumour fibroblasts promotes tumour progression in oesophageal cancer by activation of the Wnt/β-catenin signalling pathway.
Fu L; Zhang C; Zhang LY; Dong SS; Lu LH; Chen J; Dai Y; Li Y; Kong KL; Kwong DL; Guan XY
Gut; 2011 Dec; 60(12):1635-43. PubMed ID: 21672941
[TBL] [Abstract][Full Text] [Related]
6. WNT4 secreted by tumor tissues promotes tumor progression in colorectal cancer by activation of the Wnt/β-catenin signalling pathway.
Yang D; Li Q; Shang R; Yao L; Wu L; Zhang M; Zhang L; Xu M; Lu Z; Zhou J; Huang L; Huang X; Cheng D; Yang Y; Yu H
J Exp Clin Cancer Res; 2020 Nov; 39(1):251. PubMed ID: 33222684
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer.
Unterleuthner D; Neuhold P; Schwarz K; Janker L; Neuditschko B; Nivarthi H; Crncec I; Kramer N; Unger C; Hengstschläger M; Eferl R; Moriggl R; Sommergruber W; Gerner C; Dolznig H
Angiogenesis; 2020 May; 23(2):159-177. PubMed ID: 31667643
[TBL] [Abstract][Full Text] [Related]
8. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
9. Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression.
Mir R; Pradhan SJ; Patil P; Mulherkar R; Galande S
Oncogene; 2016 Mar; 35(13):1679-91. PubMed ID: 26165840
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
[TBL] [Abstract][Full Text] [Related]
11. Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer.
Dietinger V; García de Durango CR; Wiechmann S; Boos SL; Michl M; Neumann J; Hermeking H; Kuster B; Jung P
Cell Commun Signal; 2020 Jun; 18(1):102. PubMed ID: 32586342
[TBL] [Abstract][Full Text] [Related]
12. EGFL6 promotes cell proliferation in colorectal cancer via regulation of the WNT/β-catenin pathway.
Zhang QW; Zhang XT; Tang CT; Lin XL; Ge ZZ; Li XB
Mol Carcinog; 2019 Jun; 58(6):967-979. PubMed ID: 30693973
[TBL] [Abstract][Full Text] [Related]
13. Study of Wnt2 secreted by A-549 cells in paracrine activation of β-catenin in co-cultured mesenchymal stem cells.
Petrov NS; Popov BV
Biochemistry (Mosc); 2014 Jun; 79(6):524-30. PubMed ID: 25100010
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer cell-derived exosomes containing miR-10b regulate fibroblast cells via the PI3K/Akt pathway.
Dai G; Yao X; Zhang Y; Gu J; Geng Y; Xue F; Zhang J
Bull Cancer; 2018 Apr; 105(4):336-349. PubMed ID: 29496262
[TBL] [Abstract][Full Text] [Related]
15. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
[TBL] [Abstract][Full Text] [Related]
16. The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5.
Zhang M; Weng W; Zhang Q; Wu Y; Ni S; Tan C; Xu M; Sun H; Liu C; Wei P; Du X
J Hematol Oncol; 2018 Sep; 11(1):113. PubMed ID: 30185232
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of WNT2 in villi of unexplained recurrent spontaneous abortion patients may cause trophoblast cell dysfunction via downregulated Wnt/β-catenin signaling pathway.
Li N; Li S; Wang Y; Wang J; Wang K; Liu X; Li Y; Liu J
Cell Biol Int; 2017 Aug; 41(8):898-907. PubMed ID: 28627774
[TBL] [Abstract][Full Text] [Related]
18. Reduced CD146 expression promotes tumorigenesis and cancer stemness in colorectal cancer through activating Wnt/β-catenin signaling.
Liu D; Du L; Chen D; Ye Z; Duan H; Tu T; Feng J; Yang Y; Chen Q; Yan X
Oncotarget; 2016 Jun; 7(26):40704-40718. PubMed ID: 27302922
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA LINC00968 attenuates drug resistance of breast cancer cells through inhibiting the Wnt2/β-catenin signaling pathway by regulating WNT2.
Xiu DH; Liu GF; Yu SN; Li LY; Zhao GQ; Liu L; Li XF
J Exp Clin Cancer Res; 2019 Feb; 38(1):94. PubMed ID: 30791958
[TBL] [Abstract][Full Text] [Related]
20. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.
Ren J; Ding L; Zhang D; Shi G; Xu Q; Shen S; Wang Y; Wang T; Hou Y
Theranostics; 2018; 8(14):3932-3948. PubMed ID: 30083271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
